NCT03565094View on ClinicalTrials.gov

Single Dose of Lu AF28996 to Healthy Young Men

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

August 17, 2019

Study Completion Date

August 21, 2019

Conditions
Healthy
Interventions
DRUG

Lu AF28996 solution

"Oral solution (0.1-0.2 mg/mL)~Following each cohort, a dosing conference will be held where tolerability, safety and preliminary PK results from the previous cohorts will be reviewed before deciding on the next doses"

DRUG

Lu AF28996 capsule

hard capsule orally QD: one dose lower than the highest dose level in part A

Trial Locations (1)

Unknown

QPS Netherlands BV, Groningen

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT03565094 - Single Dose of Lu AF28996 to Healthy Young Men | Biotech Hunter | Biotech Hunter